[Click eStock] "Angel Robotics, Expected to Lead the Wearable Robot Market"

Korea Investment & Securities on the 29th predicted that Angel Robotics will quickly capture the early market of the high-growth wearable robot sector. No investment opinion or target price was provided.

Angel Robotics is a specialized company in wearable robots that complement human physical limitations. Its main product is Angel MEDI, a rehabilitation medical robot, and other product lines include Angel GEAR, an industrial robot, and Angel SUIT, a daily life assistance robot.

Researcher Yoon Cheol-hwan of Korea Investment & Securities forecasted that Angel Robotics' sales this year will increase by 75% compared to the same period last year, reaching 9 billion KRW, and next year will turn profitable with a 131% increase to 20.8 billion KRW.

Researcher Yoon said, "The main product, Angel MEDI, is easy to attach and detach and has lineups for both adults and pediatric patients, so benefits are expected from the recent trends of aging population and increasing number of children with disabilities." He added, "Attention should be paid to the expansion of applications due to the Class 3 medical device certification and the application of medical insurance fees."

He continued, "Angel GEAR has secured references from large corporations and has been designated as an item in the smart safety equipment support project by the Korea Occupational Safety and Health Agency, which is expected to benefit from the enforcement of the Serious Accident Punishment Act."

In particular, he analyzed that the company has established a high entry barrier by securing more than 50% internalization of key component technologies. Researcher Yoon said, "There is a possibility that Angel Robotics will become the main player quickly capturing the early market of the high-growth wearable robot sector," and "significant sales growth is expected through increased market penetration and full-scale overseas expansion." He added, "Accordingly, the operating leverage effect and progress in component internalization rate will also lead to a significant improvement in cost ratio."